What’s the difference between genetic engineering and eugenics?
By Robert Gebelhoff,
The Washington Post
| 02. 22. 2016
Untitled Document
For a half-century, the ethics of human genetic engineering have been discussed in the abstract. Because the tools to edit DNA didn’t exist, the question was more a thought experiment than a real concern.
Today, though, the conversation has completely changed. There has been a frenzy of excitement around the possibilities of CRISPR-Cas9. The technology, which allows scientists to design proteins that unzip and replace chunks of DNA as they please, makes it possible to edit genes quickly and cheaply. Investors have poured hundreds of millions of dollars into the innovation, which seems to have endless possibilities: making crops more resilient to diseases, designing mosquitoes so they can’t carry malaria — maybe even eliminating diseases among humans by altering the genes we pass on.
Scientists are confident that the technology could one day eliminate genetic disorders in humans. However, the research is still very young, and there are major ethical questions attached to editing human DNA that the emergence of CRISPR makes even more pressing: Wouldn’t editing out inheritable traits from the human population simply amount to eugenics...
Related Articles
By Daphne O. Martschenko and Julia E. H. Brown, Hastings Bioethics Forum | 01.14.2026
There is growing concern that falling fertility rates will lead to economic and demographic catastrophe. The social and political movement known as pronatalism looks to combat depopulation by encouraging people to have as many children as possible. But not just...
By Paula Siverino Bavio, BioNews | 01.12.2026
For more than ten years, gestational surrogacy in Uruguay existed in a state of legal latency: provided for by law, carefully regulated as an exception, yet without a single birth to make it real.
That situation changed with the arrival...
By Hannah Devlin, The Guardian | 01.08.2026
Scientists claim to have “rejuvenated” human eggs for the first time in an advance that they predict could revolutionise IVF success rates for older women.
The groundbreaking research suggests that an age-related defect that causes genetic errors in embryos could...
By Katherine Long, The Wall Street Journal | 12.27.2025
Nia Trent-Wilson owes $182,889.63 in medical bills for a baby that wasn’t hers.
In late 2021, she agreed to act as a surrogate through an agency that paired her with a gay couple from Washington, D.C. The terms were typical...